FindTrial
Sign In

Study on the level of nerve growth factor in preschool children with OSA combined with cognitive dysfunction

Study on the level of nerve growth factor in preschool children with OSA combined with cognitive dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040647
Enrollment
Unknown
Registered
2020-12-05
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea

Interventions

Case group:Cognitive function level
Control group:Cognitive function level

Sponsors

Children's Hospital Affiliated to Capital Institute of Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1. Aged 3 to 6 years old; 2. The course of disease was more than 3 months; 3. PSG examination was completed, which met icsd-3 OSA diagnostic criteria; 4. The Wechsler scale was completed.

Exclusion criteria

Exclusion criteria: 1. Children with central apnea; 2. Patients with acute and chronic infection; 3. Mental retardation; 4. Patients with maxillofacial dysplasia such as short mandible, micrognathia and megaglossia; 5. Children with metabolic system, cardiovascular system, genetic disease, neuromuscular disease and mental disease were found.

Design outcomes

Primary

MeasureTime frame
Brain derived neurotrophic factor;—

Secondary

MeasureTime frame
Nerve growth factor;—

Countries

China

Contacts

Public ContactChang Li

Children's Hospital Affiliated to Capital Institute of Pediatrics

changli76@163.com+86 13671250562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026